| OAB0202 | The fast and the continuous: dolutegravir-based antiretroviral therapy achieves impressive viral load suppression in CALHIV in the short- and long-term | Oral abstract session with live Q&A | ARV management strategies in paediatric and adolescent populations |
| OAB0205 | Probability of AIDS and non-AIDS-related mortality of early-treated children living with HIV-1 | Oral abstract session with live Q&A | ARV management strategies in paediatric and adolescent populations |
| PEMOB30 | Optimizing DTG uptake amongst children living with HIV in Ikom rural communities attending ART clinic at Comprehensive Health Center (CHC) Ikom, Cross River State | Poster exhibition | ARV management strategies in paediatric and adolescent populations |
| EPA065 | Ex vivo HIV suppression in foreskin tissue after oral dosing of F/TDF and F/TAF in young African males | E-poster | ARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics |
| EPA066 | Mode of interaction of CD4-CD4i antibody hybrids to HIV-1 envelope glycoproteins | E-poster | ARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics |
| EPA067 | Small-molecule CD4-mimetic compounds expose vulnerable HIV-1 Env epitopes and contact the highly conserved aspartic acid 368 | E-poster | ARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics |
| EPA068 | Metformin acts on HIV reservoirs to facilitate their recognition by the immune system | E-poster | ARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics |
| EPA069 | Dual antiretroviral loaded nanoparticles for long-acting suppressive HIV therapy | E-poster | ARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics |
| PELBA03 | In-vitro/ ex-vivo contribution of antiretroviral drug and alcohol exposure to blood-brain barrier disruption: relevance to the pathogenesis of HIV-1 associated neurological disorder | Poster exhibition | ARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics |
| PEMOA29 | In vitro release and in vivo pharmacokinetics of antiretroviral drugs from ultra-long-acting polymeric implants: towards better outcomes for HIV prevention and treatment | Poster exhibition | ARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics |